These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
290 related articles for article (PubMed ID: 27342768)
1. Global burden of drug-resistant tuberculosis in children: a mathematical modelling study. Dodd PJ; Sismanidis C; Seddon JA Lancet Infect Dis; 2016 Oct; 16(10):1193-1201. PubMed ID: 27342768 [TBL] [Abstract][Full Text] [Related]
2. Global burden of latent multidrug-resistant tuberculosis: trends and estimates based on mathematical modelling. Knight GM; McQuaid CF; Dodd PJ; Houben RMGJ Lancet Infect Dis; 2019 Aug; 19(8):903-912. PubMed ID: 31281059 [TBL] [Abstract][Full Text] [Related]
3. Prevalence of drug-resistant tuberculosis and imputed burden in South Africa: a national and sub-national cross-sectional survey. Ismail NA; Mvusi L; Nanoo A; Dreyer A; Omar SV; Babatunde S; Molebatsi T; van der Walt M; Adelekan A; Deyde V; Ihekweazu C; Madhi SA Lancet Infect Dis; 2018 Jul; 18(7):779-787. PubMed ID: 29685458 [TBL] [Abstract][Full Text] [Related]
4. Global and Regional Burden of Isoniazid-Resistant Tuberculosis. Yuen CM; Jenkins HE; Rodriguez CA; Keshavjee S; Becerra MC Pediatrics; 2015 Jul; 136(1):e50-9. PubMed ID: 26034243 [TBL] [Abstract][Full Text] [Related]
5. Epidemiology of antituberculosis drug resistance (the Global Project on Anti-tuberculosis Drug Resistance Surveillance): an updated analysis. Aziz MA; Wright A; Laszlo A; De Muynck A; Portaels F; Van Deun A; Wells C; Nunn P; Blanc L; Raviglione M; Lancet; 2006 Dec; 368(9553):2142-54. PubMed ID: 17174706 [TBL] [Abstract][Full Text] [Related]
6. Clinical management of adults and children with multidrug-resistant and extensively drug-resistant tuberculosis. Dheda K; Chang KC; Guglielmetti L; Furin J; Schaaf HS; Chesov D; Esmail A; Lange C Clin Microbiol Infect; 2017 Mar; 23(3):131-140. PubMed ID: 27756712 [TBL] [Abstract][Full Text] [Related]
7. The evolving epidemic of drug-resistant tuberculosis among children in Cape Town, South Africa. Seddon JA; Hesseling AC; Marais BJ; Jordaan A; Victor T; Schaaf HS Int J Tuberc Lung Dis; 2012 Jul; 16(7):928-33. PubMed ID: 22583610 [TBL] [Abstract][Full Text] [Related]
8. Drug resistance pattern and mutation pattern in pediatric tuberculosis: Study from north India. Khurana P; Saigal K; Ghosh A Indian J Tuberc; 2021 Oct; 68(4):481-484. PubMed ID: 34752317 [TBL] [Abstract][Full Text] [Related]
9. The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling. Houben RM; Dodd PJ PLoS Med; 2016 Oct; 13(10):e1002152. PubMed ID: 27780211 [TBL] [Abstract][Full Text] [Related]
10. Burden of Multidrug Resistant Mycobacterium tuberculosis Among New Cases in Al-Madinah Al-Monawarah, Saudi Arabia. Elhassan MM; Hemeg HA; Elmekki MA; Turkistani KA; Abdul-Aziz AA Infect Disord Drug Targets; 2017; 17(1):14-23. PubMed ID: 27848902 [TBL] [Abstract][Full Text] [Related]
12. Prevalence of isoniazid resistance-conferring mutations associated with multidrug-resistant tuberculosis in Free State Province, South Africa. Pitso L; Potgieter S; Van der Spoel van Dijk A S Afr Med J; 2019 Aug; 109(9):659-664. PubMed ID: 31635590 [TBL] [Abstract][Full Text] [Related]
13. First-line tuberculosis drug resistance patterns and associated risk factors in Germany, 2008-2017. Glasauer S; Altmann D; Hauer B; Brodhun B; Haas W; Perumal N PLoS One; 2019; 14(6):e0217597. PubMed ID: 31188848 [TBL] [Abstract][Full Text] [Related]
14. Molecular characterization of multidrug-resistant Mycobacterium tuberculosis (MDR-TB) isolates identifies local transmission of infection in Kuwait, a country with a low incidence of TB and MDR-TB. Al-Mutairi NM; Ahmad S; Mokaddas EM Eur J Med Res; 2019 Dec; 24(1):38. PubMed ID: 31806020 [TBL] [Abstract][Full Text] [Related]
15. Genetic diversity of Mycobacterium tuberculosis isoniazid monoresistant and multidrug-resistant in Rio Grande do Sul, a tuberculosis high-burden state in Brazil. Esteves LS; Dalla Costa ER; Vasconcellos SEG; Vargas A; Ferreira Junior SLM; Halon ML; Ribeiro MO; Rodenbusch R; Gomes HM; Suffys PN; Rossetti MLR Tuberculosis (Edinb); 2018 May; 110():36-43. PubMed ID: 29779771 [TBL] [Abstract][Full Text] [Related]
16. Management of multidrug resistant tuberculosis. Daley CL; Caminero JA Semin Respir Crit Care Med; 2013 Feb; 34(1):44-59. PubMed ID: 23460005 [TBL] [Abstract][Full Text] [Related]
17. National survey of drug-resistant tuberculosis in China. Zhao Y; Xu S; Wang L; Chin DP; Wang S; Jiang G; Xia H; Zhou Y; Li Q; Ou X; Pang Y; Song Y; Zhao B; Zhang H; He G; Guo J; Wang Y N Engl J Med; 2012 Jun; 366(23):2161-70. PubMed ID: 22670902 [TBL] [Abstract][Full Text] [Related]
18. High Prevalence of inhA Promoter Mutations among Patients with Drug-Resistant Tuberculosis in KwaZulu-Natal, South Africa. Niehaus AJ; Mlisana K; Gandhi NR; Mathema B; Brust JC PLoS One; 2015; 10(9):e0135003. PubMed ID: 26332235 [TBL] [Abstract][Full Text] [Related]
19. Management of difficult multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis: update 2012. Chang KC; Yew WW Respirology; 2013 Jan; 18(1):8-21. PubMed ID: 22943408 [TBL] [Abstract][Full Text] [Related]
20. Multidrug-resistant tuberculosis in Uzbekistan: results of a nationwide survey, 2010 to 2011. Ulmasova DJ; Uzakova G; Tillyashayhov MN; Turaev L; van Gemert W; Hoffmann H; Zignol M; Kremer K; Gombogaram T; Gadoev J; du Cros P; Muslimova N; Jalolov A; Dadu A; de Colombani P; Telnov O; Slizkiy A; Kholikulov B; Dara M; Falzon D Euro Surveill; 2013 Oct; 18(42):. PubMed ID: 24176581 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]